Gilead's HIV combo wins EU approval; CTI moves toward FDA with Baxalta-partnered cancer drug;

@FierceBiotech: With Pfizer and Allergan set for a $160B megamerger, what becomes of R&D? Report | Follow @FierceBiotech

@JohnCFierce: So Ian Read remains CEO. Gets $AGN at a pretty decent price, Gets his Irish domicile. Looking for $2B in cuts. Read must be pretty chuffed. | Follow @JohnCFierce

@DamianFierce: I thought Ian Read would be taller. Item | Follow @DamianFierce

> Genvoya, Gilead Sciences' ($GILD) combination HIV treatment, won European approval. The FDA signed off on the drug earlier this month. Item

> CTI BioPharma ($CTIC) began a rolling FDA submission for pacritinib, its Baxalta ($BXLT)-partnered treatment for myelofibrosis. The company expects to complete its application by the end of the year. News

> Chinese biotech Generon is partnering with the Mayo Clinic on a Phase II study testing its investigational F-652 in alcoholic hepatitis. More

Medical Device News

@FierceMedDev: ICYMI Friday: Bard to buy Liberator for $181M to improve access to home care market. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Boston Scientific earns CE mark for second-gen Watchman implant to prevent stroke. More | Follow @VarunSaxena2

@EmilyWFierce: ICYMI Friday: Cancer diagnostics company closes up shop after 6-year FTC investigation. Article | Follow @EmilyWFierce

> Startup gets $36.5M to conduct U.S. pivotal trial for novel endoscopic weight loss device. More

> CardioDiagnostics gets in on patient monitoring with plans for $7M fundraise. Article

> Mindray Medical shells out $25M to settle pulse oximeter patent battle with Masimo. Story

Pharma News

@FiercePharma: CBN: Multinational drugmakers face uphill battle in China. FiercePharmaAsia story | Follow @FiercePharma

@CarlyHFierce: UPDATED: Pfizer finally gets its inversion with $160B Allergan megamerger agreement. Article | Follow @CarlyHFierce

> Takeda's Velcade successor gets quick FDA approval. Item

> Amgen's Repatha scores an exclusive with CVS. Story

> Novartis scores new approvals for Cosentyx in Europe. Article

Animal Health News

> Virginia Tech preps dog trial of new method to improve glioblastoma treatment. Report

> Zoetis ups the ante in prevention with new flu vaccine and flea fighter for dogs. More

> Oasmia chairman is optimistic about animal health despite downsized IPO. Story

> Kuddly joins herd of veterinary apps with $1.5M seed round. Item

> Taco Bell joins fast food peers with cage-free egg pledge. Article

Biotech IT News

> Molecular Health raises $27M to advance data-crunching tech. News

> Illumina to make 5,000-genome autism database available through BaseSpace. Report

> Amazon shares landmark cancer genome data sets on cloud platform. Story

> FDA gives scientists freedom to tweet in long-awaited social media policy. Item

> AstraZeneca inks deal to install robots at new R&D facility. Article

Pharma Marketing News

> Amgen nabs another PCSK9 exclusive, this time with giant CVS. Report

> Better together? Savvy e-patients may make pharma marketing smarter. Story

> Teva goes for laughs in new social media campaign for COPD. Item

> AstraZeneca aims at a 'broader' target with services-based lung cancer effort. Article

> Healthcare ad and media agencies break into annual 'best workplaces' ranking. More

Suggested Articles

A who’s who of Big Pharmas, including Pfizer, Johnson & Johnson and Merck, have banded together to bolster the development of new antibiotics.

Bayer's finerenone beat placebo at slowing kidney disease and cut the risk of heart attacks and strokes in diabetic kidney disease patients.

The National Institute of Allergy and Infectious Diseases is launching a new clinical trials network for COVID-19.